Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Published Scientific Evidence

Category: (Obstetrics-Related Cardiomyopathy)

Anumana’s ECG-AI® technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.

October
21
2026
{post_date: F d, Y}
JACC

Validating ECG-Based Artificial Intelligence Models for Cardiomyopathy Detection in Obstetric Patients: A Multisite International Study

AbstractBackgroundCardiomyopathy significantly impacts maternal health worldwide. Artificial intelligence–enabled electrocardiograms (AI-ECG) have shown effectiveness in detecting left ventricular systolic dysfunction (LVSD) in adults and limited obstetric cohorts; however, broad validation in…